GENZYME AND BROOKWOOD ANNOUNCE COLLABORATION

A A

Genzyme Pharmaceuticals, a business unit of Genzyme Corporation, and Brookwood Pharmaceuticals, Inc., have announced a broad collaboration to develop drug delivery solutions, with an initial focus on peptide delivery.
The partnership offers customized solutions for parenteral formulations by combining expertise in design for peptide delivery, peptide synthesis, and drug delivery technologies.
Genomics and Proteomics